Dakshidin Corporation Stock Today

DKSC Stock  USD 0  0.0002  12.50%   

Performance

11 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Over 57

 
High
 
Low
Above Average
Dakshidin is trading at 0.0014 as of the 3rd of December 2024, a 12.5% down since the beginning of the trading day. The stock's open price was 0.0016. Dakshidin has over 57 % chance of experiencing financial distress in the next 2 years of operation, but had a somewhat good returns during the last 90 days. Equity ratings for Dakshidin Corporation are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of September 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBDcannabis-based medical product company. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada. Dakshidin is traded on OTC Exchange in the United States. More on Dakshidin Corporation

Moving against Dakshidin Pink Sheet

  0.87HLN Haleon plcPairCorr
  0.84TAK Takeda PharmaceuticalPairCorr
  0.81MKKGY Merck KGaA ADRPairCorr
  0.79MKGAF MERCK KommanditgesellsPairCorr
  0.79PKX POSCO HoldingsPairCorr
  0.74HYMTF Hyundai MotorPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Dakshidin Pink Sheet Highlights

Business ConcentrationDrug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Dakshidin Corporation [DKSC] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 50 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dakshidin's market, we take the total number of its shares issued and multiply it by Dakshidin's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Dakshidin conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. Dakshidin generates negative cash flow from operations
Check Dakshidin Probability Of Bankruptcy

Dakshidin Risk Profiles

Dakshidin Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Dakshidin without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Other Information on Investing in Dakshidin Pink Sheet

Dakshidin financial ratios help investors to determine whether Dakshidin Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Dakshidin with respect to the benefits of owning Dakshidin security.